跳至主要内容
临床试验/CTRI/2018/07/015002
CTRI/2018/07/015002招募中2 期

A randomised trial of prednisolone and methotrexate Vs prednisolone alone to assess the adjuvant potential of methotrexate in mucosal/ limited mucocutaneous pemphigus vulgaris

PGIMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
PGIMER

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of pemphigus vulgaris with oral mucosal lesions with no cutaneous involve- ment or limited cutaneous involvement (i.e. less than 5% BSA)
  • 2. Attending the immunobullous disease clinic of the Department of Dermatology for the first time
  • 3. Age more than 18 years.
  • 4. Willing for biweekly follow up for 1 month & monthly follow up visits for atleast 8 months thereafter

排除标准

  • 1. Individuals upto 18 years of age
  • 2. Inability to come for follow up till 9 months
  • 3. Pregnant and lactating females
  • 4. Elderly patients aged 70 years or older for practical difficulty in following up or unre- liable patients
  • 5. Significant anaemia, leukopenia or thrombocytopenia
  • 6. Chronic infection or immunosuppressed state (e.g TB, HIV)
  • 7. Heavy alcohol consumption or hepatic impairment
  • 8. Renal insufficiency
  • 9. History suggestive of allergy to methotrexate
  • 10. Planning to start a family in next 12 months or not willing for contraception

研究者

发起方
PGIMER

相似试验

进行中(未招募)
1 期
Randomized controlled trial to evaluate the efficacy of per-protocol administration of Methylprednisolone compared to Dexamethasone in SARS-CoV-2 infections requiring respiratory support.Hospitalized patients with COVID-19 requiring respiratory supportMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862
EUCTR2020-006054-43-ITniversità degli Studi di Trieste680
进行中(未招募)
不适用
Randomized study with methylprednisolone 1mg/kg/day for treatment of grade I acute GvHDpatients developing acute GvHD grade IMedDRA version: 14.1Level: LLTClassification code 10000802Term: Acute GVH diseaseSystem Organ Class: 100000004870
EUCTR2008-000413-29-ITGITMO GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO,CELLULE STAMINALI EMOPOIETICHE E TERAPIA CELLULARE - ONLUS
已完成
不适用
A combination of methylprednisolone and prednisolone and a combination of Methylprednisolone, prednisolone and mizoribine for systemic lupus erythematosus in children: A randomized controlled trial of efficacy and safety izolibin for (JSRDC04)systematic lupus erythematosus
JPRN-C000000378Japanese Study Group of Renal Disease in Children(JSRDC)60
已完成
不适用
A randomised controlled trial of prednisone versus placebo in the management of human immunodeficiency virus (HIV)-infected patients presenting with mild to moderate Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome after commencing Highly Active Antiretroviral TherapyHIV and Tuberculosis-associated Immune Reconstitution Inflammatory SyndromeInfections and InfestationsHuman immunodeficiency virus (HIV)
ISRCTN21322548niversity of Cape Town - Research Ethics Committee, Faculty of Health Sciences (South Africa)100
已完成
不适用
Randomized Clinical Trial on Prednisolone Vs ACTH for the treatment of Infantile SpasmsInfantile spasms
SLCTR/2010/010Department of Paediatrics Faculty of Medicine, Colombo136
To evaluate the adjuvant potential of methotrexate ... | 临床试验